It is reported that patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease (NFALD) were treated with aggliptin for 12 months, and the scores of nonalcoholic fatty hepatitis (NASH), ferritin, insulin and collagen IV 7S were significantly improved [11]. This evidence concerns the gene INS and type 2 diabetes mellitus.